GM-CSF for Immunomodulation Following Trauma (GIFT) Study

Therapuetic Areas:Other
Age Range:1 - 17
Start Date:December 2011
End Date:December 2019
Contact:Mark W Hall, MD

Use our guide to learn which trials are right for you!

The GIFT study is a prospective, multi-center, interventional trial using the drug GM-CSF for
the reversal of innate immune suppression in critically injured children. The study will be
conducted in two phases, a dose-finding phase then an efficacy phase. The dose-finding phase
is the current active phase of the study. The central hypothesis of the study is that
immunomodulation with GM-CSF will result in reduction in the risk of nosocomial infection
after critical injury in high-risk children through safe, rapid, and sustained improvement in
innate immune function.

The current phase of the study is an open-label dose-finding phase in which critically
injured children undergo prospective, serial immune function testing in the first few days
after injury. If a subject's immune function (as measured by whole blood ex vivo LPS-induced
TNF-alpha production capacity) is below a critical threshold, the subject will receive GM-CSF
at a dose of 30, 62, or 125 mcg/m2 per day for three days. Enrollment is stratified by
pubertal status (Tanner 1 or Tanner > 1) and by presence or absence of severe traumatic brain
injury (TBI). Dose-finding is being conducted independently in each of these strata. The
outcome variable for the dose-finding phase of the GIFT study is restoration of TNF-alpha
production capacity and monocyte HLA-DR expression by the end of treatment, persisting to
post-trauma day 7. A subsequent randomized, placebo-controlled trial with nosocomial
infection as the primary outcome variable is planned once dose-finding is complete. This
study is being conducted by the NICHD's Collaborative Pediatric Critical Care Research
Network (CPCCRN) with Nationwide Children's Hospital as the primary site. The study design
information currently displayed on this site refers to the dose-finding phase of the project.

Inclusion Criteria:

- Admission to the PICU at a GIFT study site with a primary diagnosis of blunt or
penetrating trauma that occurred within the last 72 hours.

- Age 1 - 17 years

- Provisional Injury Severity Score (ISS) > 10

- Presence of an endotracheal tube at the time of enrollment

Exclusion Criteria:

- DNR status or care team/family is considering plans for withdrawal of life-sustaining

- Strong suspicion of injuries related to child abuse, in the opinion of the treating

- Persistence (after treatment) of any of the following in the PICU before enrollment:
Fixed, dilated pupils; Glasgow Coma Scale score of 3 (in the absence of neuromuscular
blocking drugs); or presence of a new, severe neurologic injury at the time of
enrollment which, in the opinion of the treating physician, is highly likely to lead
to a diagnosis of brain death

- Cardiopulmonary arrest requiring CPR documented by EMS or hospital personnel prior to
subject identification

- Burn injury of any kind (scald, fire, chemical)

- Patients receiving acute or chronic immunosuppressive therapy (e.g., systemic
corticosteroids, calcineurin inhibitors, mycophenolate, azathioprine) at the time of

- Patients with severe leukopenia (white blood cell count < 1000 cells/mm3) at the time
of injury as the result of myeloablative chemotherapy or radiation

- Pregnancy

- Autoimmune thrombocytopenia, myelodysplastic syndromes with > 20% marrow blast cells,
or known allergy/hypersensitivity to GM-CSF

- Previously enrolled in the GIFT study
We found this trial at
Cincinnati, Ohio 45267
Phone: 513-636-4259
Cincinnati, OH
Click here to add this to my saved trials
700 Childrens Drive
Columbus, Ohio 43205
(616) 722-2000
Phone: 614-722-3438
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
Columbus, OH
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
Phone: 800-879-2467
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Philadelphia, PA
Click here to add this to my saved trials
13123 E 16th Ave
Aurora, Colorado 80045
(720) 777-1234
Phone: 720-777-1234
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
Aurora, CO
Click here to add this to my saved trials
3901 Beaubien St
Detroit, Michigan 48201
(313) 745-5437
Phone: 313-745-5437
Children's Hospital of Michigan Since 1886, the Children's Hospital of Michigan has been dedicated to...
Detroit, MI
Click here to add this to my saved trials
3414 Fifth Avenue
Pittsburgh, Pennsylvania 15213
Phone: 412-692-5325
Pittsburgh, PA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Phone: 314-286-1169
Saint Louis, MO
Click here to add this to my saved trials
111 Michigan Ave NW
Washington, District of Columbia
(202) 476-5000
Phone: 202-476-5000
Childrens National Medical Center As the nation’s children’s hospital, the mission of Children’s National Medical...
Click here to add this to my saved trials